TSA vs RSA in Glenohumeral Osteoarthritis
Key facts
- Where
- Edmonton, Kingston, Ottawa, and Winnipeg, CanadaSee the 4 sites
Where in Canada
- University of AlbertaEdmonton, CanadaContact: Martin Bouliane, MDNot yet recruiting
- Kingston General Hospital (Site-Watkins 3)Kingston, CanadaContact: Fiona HowellsTaking people
- The Ottawa HospitalOttawa, CanadaContact: Peter Lapner, MDTaking people
- Pan Am Clinic FoundationWinnipeg, CanadaContact: Sheila McRaeNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Ottawa Hospital Research Institute
- Trial code
- NCT04228419
- Record updated
- 25 March 2025
- Original description
This study will compare total shoulder arthroplasty (TSA) reverse shoulder arthroplasty (RSA) procedures, in the context of a prospective, randomized-controlled trial to determine the optimal treatment in patients 65 years of age and older, and equal to or less than 15 degrees of glenoid retroversion, who have glenohumeral osteoarthritis.Read full original descriptionShow less
Study Evaluating Reverse Versus Anatomic Shoulder Arthroplasty Techniques in the Treatment of Osteoarthritis: Protocol
This study will compare total shoulder arthroplasty (TSA) reverse shoulder arthroplasty (RSA) procedures, in the context of a prospective, randomized-controlled trial to determine the optimal treatment in patients 65 years of age and older, and equal to or less than 15 degrees of glenoid retroversion, who have glenohumeral osteoarthritis.
Inclusion: Patients who have failed standard non-surgical management of their idiopathic shoulder osteoarthritis who would benefit from a shoulder arthroplasty. Failed medical management will be defined as persistent pain and disability despite adequate standard non-operative management for 6 months. Medical management will be defined as:; The use of drugs including analgesics and non-steroidal anti-inflammatory drugs; Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.); Activity modification; Imaging, and intra-operative findings confirming advanced glenohumeral cartilage loss; Patients may present with a glenoid deficiency and </=15 degrees of retroversion; 65 years of age and older.
Exclusion: History of previous shoulder surgery on affected side; Active joint or systemic infection; Major medical illness (life expectancy less than 1 year or unacceptably high operative risk); Psychiatric illness that precludes informed consent; Rotator cuff arthropathy; Significant muscle paralysis; Charcot's arthropathy; Unable to understand the consent form/process; Pregnancy; Unwilling to be followed for the duration of the study; Retroversion cannot be surgically corrected to within 10 degrees of neutral.